Navigation Links
Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance
Date:7/22/2009

========= ========= ========= ========= Earnings per share - diluted $1.06 $.88 20% $2.25 $1.85 22% ========= ========= ========= ========= Dividends paid per share $.49 $.47 4% $.98 $.94 4% Weighted-average Shares outstanding (thousands) - basic 1,097,184 1,093,778 1,097,195 1,093,831 Weighted-average Shares outstanding (thousands) - diluted 1,097,213 1,093,832 1,097,226 1,093,989 NM - not meaningful 

    Eli Lilly and Company
    Operating Results  (Unaudited) - Pro forma Non-GAAP
    (Dollars in millions, except per share data)

                          Three Months Ended            Six Months Ended
                                June 30                      June 30
                      2009(a) 2008(b)( c ) % Chg.  2009(a) 2008(b)( c ) % Chg.
                     ---------------------------- ----------------------------
    Net product sales $5,113.3  $5,055.2      1%  $10,005.1  $9,790.0      2%
    Collaboration
     and other
     revenue             179.5     196.0     (8)%     334.7     371.7    (10)%
                     --------- ---------          --------- ---------
    Total Revenue      5,292.8   5,251.2      1%   10,339.8  10,161.7      2%

    Cost of sales        947.4   1,183.3    (20)%   1,763.8   2,338.4    (25)%
    Research and
     development       1,040.4     994.3      5%    1,987.7   1,907.4      4%
    Marketing,
     selling and
     administrative    1,708.2   1,739.6     (2)%   3,237.4   3,314.6     (2)%
    Acquired in-
     process research
     and development         -         -     NM           -         -     NM
    Asset impairments,
     restructuring and
     other special
     charges                 -         -  
'/>"/>
SOURCE  Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 

Related medicine news :

1. Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)
2. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
3. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
4. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
5. Lilly Declares Third-Quarter Dividend
6. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
7. Eli Lilly and Company Announces New Drug Discovery Initiative
8. NAACP & Nine Class Reps File Motion for Class Certification Against Eli Lilly in Pervasive Discrimination Case
9. ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
10. Bart Peterson to Join Lilly Leadership Team
11. Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Institute announce the first comprehensive analyses of cancer genomes. ... the DNA of cancer cells which are acquired during ... and a lung cancer, reveal for the first time ... cancers. , Lung cancer causes around one million deaths ... The number of mutations found suggest that a typical ...
(Date:12/16/2009)... work on a malaria elimination study in Africa have ... disease using cell phone records. , The scientists analyzed ... residents of Zanzibar travel and where they go. A ... of Tanzania in East Africa, Zanzibar has drastically reduced ... as part of deliberations on whether to launch a ...
(Date:12/16/2009)... from Episencial Offers Planet-Friendly Organics, Solar-Powered Manufacturing and Sustainable Packaging ... ... Los Angeles, CA (PRWEB) December 16, 2009 -- ... affordable choice in all natural skin care for their children ... for young children featuring the beloved artwork of The Very ...
(Date:12/16/2009)... half, but use in humans is still far off , , ... nature, researchers have built and tested synthetic versions of the ... other cases where blood just won,t stop flowing. , "We ... in degradable stitches, which dissolve in the body," said Erin ... Reserve University, and lead author of a report published ...
(Date:12/16/2009)... leader of Digital Pen and Paper technology and the provider ... today announced that it is ranked among the Fastest Growing ... 2009. , ... (PRWEB) December 16, ... for the capture, digitalization and management of handwritten data. Kayentis ...
Breaking Medicine News(10 mins):Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6Health News:Scientists use cell phone records to predict spread of malaria 2Health News:Scientists use cell phone records to predict spread of malaria 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 2Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 3Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 4Health News:New from Episencial: All Natural, Actively Healthy Skin Care for Babies, Kids and Planet Features Eric Carle's "The Very Hungry Caterpillar" 5Health News:Synthetic Platelets Put the Brakes on Blood Loss 2Health News:Synthetic Platelets Put the Brakes on Blood Loss 3Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2
... of Voorhees facility already ahead of scheduleMARLTON, N.J., Feb. ... sell tax exempt bonds from the New Jersey Health ... 2009. The bonds will be used to continue ... "We have our plan for finance in place and ...
... safety initiative to reduce bloodstream infections in intensive care units ... could save an estimated $3 billion dollars and 30,000 lives ... and will begin in the United Kingdom starting in April. ... in Peru and Chile. , "We ran this program in ...
... 25 Nyer Medical Group, Inc. (Nasdaq: ... as chief financial officer. Ms. Zimmerman, a certified ... of Certified Public Accountants, brings more than 30 years ... For the past ten years, Ms. Zimmerman has ...
... Colo., Feb. 25 Mesa Laboratories, Inc. (Nasdaq: ... for manufacturing quality control applications, today announced the appointment ... brings extensive experience to Mesa from his role as ... Group Inc., a registered investment adviser based in New ...
... Provide Information and Resource Safety NetWASHINGTON, Feb. 25 ... debuted a new alliance that will offer veterans, ... for information about healthcare risks experienced by those ... Health Council, made up of veterans and health ...
... Research Council commends the over 180 Members of ... House urging support for long-standing pro-life policies in upcoming ... and overseas abortions, destructive human embryo experimentation, and organizations ... The letter requests that the riders be included in ...
Other Medicine News:Health News:Virtua Health Takes Next Step for Continuing Hospital Construction 2Health News:Johns Hopkins safety team works to eliminate bloodstream infections in the nation and the world 2Health News:Mesa Labs Announces Appointment of New Director 2Health News:VVA Introduces Collaboration Between Veterans and Private Sector to Address Healthcare Needs for Vets 2Health News:FRC Commends Effort to Protect Pro-Life Riders, Prevent Taxpayer Funded Abortions 2
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... VIEW, Calif., Dec. 16 Frost ... Zachary Bujnoch, looks forward to speaking at ... Summit taking place on January 9, 2010 ... on the emerging market of consumer-based digital ... services. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, ...
(Date:12/16/2009)... Ill., Dec. 16 Naurex Inc., a ... depression and other CNS disorders based on its ... data presented at a major medical meeting showed ... and anxiolytic-like activity with no signs of the ... the NMDA receptor(1). The studies also showed ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6When Viruses 28Including H1N1 29 and Bacteria are as Close as your Fingertips 3B VirWalls New Innovation Can Disarm Killer Keyboards 6324 1When Viruses 28Including H1N1 29 and Bacteria are as Close as your Fingertips 3B VirWalls New Innovation Can Disarm Killer Keyboards 6324 2The Cancer Pain Drug Market Driven by the Continued Dominance of Opioids Will Increase From 242 3 Billion in 2008 to 243 7 Billion in 2018 6320 1The Cancer Pain Drug Market Driven by the Continued Dominance of Opioids Will Increase From 242 3 Billion in 2008 to 243 7 Billion in 2018 6320 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 1Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 2Picis ED PulseCheck Increases Security and Privacy Protection in Nearly 150 Hospitals Through the Use of DigitalPersona Biometrics 10756 3
... 30 The Laboratory Response Network (LRN), the national ... emergencies, will mark its first decade at its national ... by the Association of Public Health Laboratories (APHL), the ... Federal Bureau of Investigation (FBI) to test for agents ...
... Company preparing to initiate phase III trial -SOUTH SAN ... announced top-line results from their phase II study of ... The data was presented on March 27th at the ... of Medical Genetics by Brendan Lee, M.D., Ph.D., Howard ...
Other Medicine Technology:Nation's Laboratory Response Network Marks First Decade of Protecting Public Health 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 2Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 3Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders 4
The computer-optimized optical design produces large, brilliant images of high resolution....
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Medicine Products: